Measuring perceived effects of drinking an extract of basidiomycetes Agaricus blazei murill: A survey of Japanese consumers with cancer

BMC Complementary and Alternative Medicine

Volumn 7, Issue , 2007, Pages

  Talcott, James A ^a   Clark, Jack A ^b,d   Lee, Insu P ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c KANAZAWA UNIVERSITY   (Japan)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGARICUS BLAZEI EXTRACT; ANTINEOPLASTIC AGENT; SEN SEI RO; UNCLASSIFIED DRUG; IMMUNOLOGICAL ADJUVANT; PLANT EXTRACT;

ADULT; AGARICUS BLAZEI; AGED; ALTERNATIVE MEDICINE; ARTICLE; BASIDIOMYCETES; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; COLON CANCER; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMOGRAPHY; DISEASE COURSE; EMOTIONALITY; FEMALE; FUNCTIONAL STATUS; HUMAN; IMMUNE RESPONSE; JAPANESE; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; POSTAL MAIL; PROSTATE CANCER; PSYCHOLOGICAL WELL BEING; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RELIGION; SELF EVALUATION; SIDE EFFECT; STOMACH CANCER; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER; AGARICUS; JAPAN; MIDDLE AGED; NEOPLASM; PATIENT SATISFACTION; PHYTOTHERAPY; STATISTICS; UTILIZATION REVIEW;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGARICUS; AGED; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; PATIENT SATISFACTION; PHYTOTHERAPY; PLANT EXTRACTS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 38649137251     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-7-32     Document Type: Article

References (33)

1. Eisenberg DM Kessler RC Foster C Norlock FE Calkins DR Delbanco TL: Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993, 328:246-252. 10.1056/ NEJM199301283280406 8418405
2. Cassileth BR Lusk EJ Strouse TB Bodenheimer BJ: Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners. Ann Intern Med 1984, 101:105-112. 6732073
3. Astin JA: Why patients use alternRtive medicine: results of a national study. JAMA 1998, 279:1548-1553. 10.1001/jama.279.19.1548 9605899
4. Boon H Stewart M Kennard MA Gray R Sawka C Brown JB McWilliam C Gavin A Baron RA Aaron D Haines-Kamka T: Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol 2000, 18:2515-2521. 10893281
5. Eisenberg DM Davis RB Ettner SL Appel S Wilkey S Van Rompay M Kessler RC: Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998, 280:1569-1575. 10.1001/jama.280.18.1569 9820257
6. Talcott JA: Cancer Outcomes. Cancer Medicine Hamilton, Ontario: BC Decker Inc Kufe DW, Bast RC Jr, Hait WN, Hong WK, Pollock RE, Weicheselbaum RR, Holland JF, Frei E III 2006 7 426 433
7. Clark JA Talcott JA: Symptom indexes to assess outcomes of treatment for early prostate cancer. Med Care 2001, 39:1118-1130. 10.1097/ 00005650-200110000-00009 11567174
8. Bokhour BG Clark JA Inui TS Silliman RA Talcott JA Sexuality after treatment for early prostate cancer: Exploring the meanings of "erectile dysfunction". J Gen Intern Med 2001, 16:649-655. 1495277 11679031 10.1111/j.1525-1497.2001.00832.x0
9. Clark JA Bokhour BG Inui TS Silliman RA Talcott JA: Measuring patients' perceptions of the outcomes of treatment for early prostate cancer. Med Care 2003, 41:923-936. 10.1097/00005650-200308000-00006 12886172
10. Izawa S Inoue Y: A screening system for antioxidants using thioredoxin-deficient yeast: Discovery of thermostable antioxidant activity from Agaricus blazei. Murill Appl Microbiol Biotechnol 2004, 64:537-542. 10.1007/s00253-003-1467-4 14593506
11. Delmanto RD de Lima PL Sugui MM da Eira AF Salvadori DM Speit G Ribeiro LR: Antimutagenic effect of Agaricus blazei Murrill mushroom on the genotoxicity induced by cyclophosphamide. Mutat Res 2001, 496:15-21. 11551476
12. Menoli RC Mantovani MS Ribeiro LR Speit G Jordao BQ: Antimutagenic effects of the mushroom Agaricus blazei Murrill extracts on V79 cells. Mutat Res 2001, 496:5-13. 11551475
13. Takaku T Kimura Y Okuda H: Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J Nutr 2001, 131:1409-1413. 11340091
14. Ebina T Fujimiya Y: Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice. Biotherapy 1998, 11:259-265. 10.1023/A:1008054111445 9950102
15. Fujimiya Y Suzuki Y Oshiman K Kobori H Moriguchi K Nakashima H Matumoto Y Takahara S Ebina T Katakura R: Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis. Cancer Immunol Immunother 1998, 46:147-159. 10.1007/s002620050473 9625538
16. Mizuno M Minato K Ito H Kawade M Terai H Tsuchida H; Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei mill. Biochem Mol Biol Int 1999, 47:707-714. 10319424
17. Lee IP Ohta T Bae SM Pereira MA Steele VE: 1SY16 isloated from Agaricus blazei Murill K as a potent multipotential chemopreventive agent. Book 1SY16 isloated from Agaricus blazei Murill K as a potent multipotential chemopreventive agent (Editor ed. eds.) City: American Association of Cancer Research; 2004.
18. Nakajima A Ishida T Koga M Takeuchi T Mazda O Takeuchi M: Effect of hot water extract from Agaricus blazei Murill on antibody-producing cells in mice. Int Immunopharmacol 2002, 2:1205-1211. 10.1016/ S1567-5769(02)00056-5 12349957
19. Ahn WS Kim DJ Chae GT Lee JM Bae SM Sin JI Kim YW Namkoong SE Lee IP: Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. Int J Gynecol Cancer 2004, 14:589-594. 10.1111/j.1048-891X.2004.14403.x 15304151
20. Ware JEJ Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483. 10.1097/00005650-199206000-00002 1593914
21. Ware JE Jr Johnston SA Davies-Avery A Brook RH: Conceptualization and measurement of health for adults in the Health Insurance Study: Mental Health. Santa Monica, Calif: Rand 1979
22. Correa-Velez I Clavarino A Eastwood H: Surviving, relieving, repairing, and boosting up: Reasons for using complementary/alternative medicine among patients with advanced cancer: A thematic analysis. J Palliat Med 2005, 8:953-961. 10.1089/jpm.2005.8.953 16238508
23. Patterson RE Neuhouser ML Hedderson MM Schwartz SM Standish LJ Bowen DJ Marshall LM: Types of alternative medicine used by patients with breast, colon, or prostate cancer: Predictors, motives, and costs. J Altern Complement Med 2002, 8:477-485. 10.1089/107555302760253676 12230908
24. Jazieh AR Kopp M Foraida M Ghouse M Khalil M Savidge M Sethuraman G: The use of dietary supplements by veterans with cancer. J Altern Complement Med 2004, 10:560-564. 10.1089/1075553041323731 15253863
25. Richardson MA Sanders T Palmer JL Greisinger A Singletary SE: Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000, 18:2505-2514. 10893280
26. Foote JA Murphy SP Wilkens LR Hankin JH Henderson BE Kolonel LN: Factors associated with dietary supplement use among healthy adults of five ethnicities: The Multiethnic Cohort. Study Am J Epidemiol 2003, 157:888-897. 10.1093/aje/kwg072 12746241
27. Gunther S Patterson RE Kristal AR Stratton KL White E: Demographic and health-related correlates of herbal and specialty supplement use. J Am Diet Assoc 2004, 104:27-34. 10.1016/j.jada.2003.10.009 14702580
28. Greenlee H White E Patterson RE Kristal AR: Supplement use among cancer survivors in the Vitamins and Lifestyle (VITAL) study cohort. J Altern Complement Med 2004, 10:660-666. 15353022
29. Hedderson MM Patterson RE Neuhouser ML Schwartz SM Bowen DJ Standish LJ Marshall LM: Sex differences in motives for use of complementary and alternative medicine among cancer patients. Altern Ther Health Med 2004, 10:58-64. 15478787
30. Crocetti E Crotti N Feltrin A Ponton P Geddes M Buiatti E The use of complementary therapies by breast cancer patients attending conventional treatment Eur J Cancer 1998 34 324 328 10.1016/S0959-8049(97)10043-0 9640216
31. Paltiel O Avitzour M Peretz T Cherny N Kaduri L Pfeffer RM Wagner N Soskolne V: Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 2001, 19:2439-2448. 11331323
32. Ishihara J Sobue T Yamamoto S Sasaki S Tsugane S: Demographics, lifestyles, health characteristics, and dietary intake among dietary supplement users in Japan. Int J Epidemiol 2003, 32:546-553. 10.1093/ije/ dyg091 12913027
33. Burstein HJ Gelber S Guadagnoli E Weeks JC: Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999, 340:1733-1739. 10.1056/NEJM199906033402206 10352166